Skip to content

13F-HR filed by Rosalind Advisors, Inc.

Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 34 holding rows worth $205,636,842.

Accession
0001622627-25-000027
Filed
2025-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 34 entries on the cover page, a total value of $205,636,842 stated on the cover page (in dollars after the unit check, H1), rows summing to $205,636,842 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DELCATH SYSTEMS INC24661P807COMMON STOCK2,900,389$29,003,890dollars as filed
VERASTEM INC92337C203COMMON STOCK2,644,517$15,946,438dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM2,495,986$13,702,963dollars as filed
MYOMO INC62857J201COM NEW2,703,661$13,004,609dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock700,000$11,466,000dollars as filed
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK1,782,844$10,857,520dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK950,000$10,507,000dollars as filed
OCULAR THERAPEUTIX INC67576A100COM1,218,700$8,933,071dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW1,805,817$8,595,689dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK850,000$8,287,500dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM595,000$8,020,600dollars as filed
MEDIWOUND LTDM68830112COMMON STOCK506,893$7,866,979dollars as filed
SAVARA INC805111101COM2,654,944$7,354,195dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS100,000$6,349,000dollars as filed
INSPIREMD INC45779A846COM2,274,990$6,119,723dollars as filed
CYBIN INC23256X407COM NEW810,918$5,141,220dollars as filed
NUVATION BIO INC COM CL A67080N101Stock2,451,500$4,314,640dollars as filed
PROFOUND MED CORP74319B502COM NEW692,185$4,028,517dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock612,901$3,855,147dollars as filed
PHARVARIS NVN69605108COMMON STOCK223,627$3,510,944dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM303,864$3,506,591dollars as filed
POLYPID LTDM8001Q126COM1,018,021$2,758,837dollars as filed
MIND MEDICINE MINDMED INC60255C885COM NEW420,000$2,457,000dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS823,286$2,354,598dollars as filed
OPTINOSE INC68404V209COM256,190$2,349,262dollars as filed
COGENT BIOSCIENCES INC19240Q201COM248,285$1,487,227dollars as filed
TALPHERA INC00444T209COM NEW2,003,939$991,950dollars as filed
KIORA PHARMACEUTICALS INC49721T507COM250,059$752,678dollars as filed
KURA ONCOLOGY INC COM50127T109Stock100,000$660,000dollars as filed
ALPHA COGNITION INC02074J501COM NEW104,836$530,470dollars as filed
BIOFRONTERA INC09077D209COM NEW644,393$515,514dollars as filed
INVESCO QQQ TR46090E953PUT50,000$373,500dollars as filedput
LEXICON PHARMACEUTICALS INC528872902COM NEW1,278,900$30,000dollars as filedcall
CANDEL THERAPEUTICS INC137404959COM15,800$3,570dollars as filedput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001622627-25-000027this filing2025-05-14acceptance time not in the bulk data set